NFKB1 and inflammatory bowel disease: Inappropriate activation of the TLR4/MyD88/NF-κB signaling pathway is an important signaling pathway for the aggravation of intestinal inflammation in patients with IBD, and it is a common target of drug development for IBD patients [35].